FOLH1 and neoplasm: The model oftesting was immunodeficient mice bearing xenograft PSMA­(+) PC-3 PIPtumors (average tumor volume reached 62.4 ± 11.6 mm3), in which several doses of 51 were tested (D =20, 40, and 80 μg/kg, IP/30 days).